Australia’s Future Fund Takes a Page from Alaska
The Alaska Permanent Fund Corporation (APFC) has made two notable large bets in anti-cancer pharmaceuticals. One of their strategic investments was in Juno Therapeutics. Biotech companies in areas such as anti-cancer therapies see wealth funds as ideal capital partners due to their long-term investment horizon. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]
Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute